查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1942975

异丁基亚硝酸盐市场按产品类型、应用、最终用户和分销管道划分，全球预测（2026-2032年）

Isobutyl Nitrite Market by Product Type, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025 年异丁基亚硝酸酯市值为 1.5932 亿美元，预计到 2026 年将成长至 1.7294 亿美元，年复合成长率为 7.89%，到 2032 年将达到 2.7116 亿美元。

主要市场统计数据
基准年 2025 1.5932亿美元
预计年份：2026年 1.7294亿美元
预测年份：2032年 2.7116亿美元
复合年增长率 (%) 7.89%

为异丁基亚硝酸酯在工业应用、监管压力和战略供应链考量中的当前作用提供了一个清晰权威的框架。

本执行摘要总结了构成亚硝酸异丁酯现况的复杂跨学科考量。引言部分概述了该化合物在工业和实验室中的多种用途、影响其生产、分销和使用的复杂监管环境，以及供应链和消费行为的交织动态。这为采购合规和策略团队在不断变化的环境中寻求清晰的分析奠定了基础。

製造技术的创新、管理体制的收紧以及数位化供应链正在从根本上重塑生产、分销和终端用户趋势。

异丁基亚硝酸酯市场正经历多重变革，其生产、分销和与终端用户的互动方式都在重塑。生产製程控制的进步和更纯净合成路线的建立，拓展了产品品质的选择范围，并促进了工业级、医药级和试剂级产品之间的清晰区分。同时，多个司法管辖区日益严格的法规结构迫使生产商和经销商加强整个供应链的合规流程和可追溯性。

探讨关税变化对异丁基亚硝酸盐相关人员在采购合规和物流方面面临的营运和策略影响

2025年美国政策的变化给异丁基亚硝酸酯的生产商、进口商和下游用户带来了新的挑战。关税调整及相关贸易措施迫使相关人员重新评估筹资策略和路线选择，以在应对额外行政负担的同时维持业务连续性。这些趋势促使企业探索替代采购管道、近岸外包以及加强垂直整合，以降低贸易政策波动带来的风险。

一个多层级细分框架，将产品等级、应用管道、最终用户画像和分销管道连结起来，以揭示价值集中区域和合规风险。

详细的市场区隔揭示了不同产品配方、用途、终端用户类型和分销管道的价值和风险集中。按产品类型分析，区分了工业级、医药级和试剂级产品，每种产品都有不同的品质规格、认证要求以及对各种下游製程的适用性。根据应用领域，需求分为工业用途、实验室试剂用途、医疗用途和娱乐用途。娱乐用途市场进一步以消费者人口统计特征（18-25岁、26-35岁及35岁以上）进行分析，以揭示不同年龄层消费者在购买行为和风险认知上的差异。

不同地区的监管差异、采购惯例和行业能力如何影响供应商策略和分销模式？

区域趋势对生产基地选择、合规性和分销策略具有决定性影响。在美洲，不同司法管辖区的监管执法和海关惯例差异显着，迫使供应链管理者制定区域性合规应对措施和本地化分销策略。该地区的监管对话和执法趋势正在影响企业如何记录原产地、认证纯度以及管理敏感用途产品的监管链。

透过品质保证、合规计划、数位化分销以及製造商与经销商之间的策略伙伴关係实现竞争差异化

异丁基亚硝酸酯市场的竞争格局呈现出多元化的格局，既有成熟的化学品製造商，也有专业供应商，还有灵活敏捷、以数位化为先的经销商。主要企业透过投资品质保证、法规遵循计画和可追溯性平台来脱颖而出，这些平台能够证明所有权炼和分析来源。製造商与授权经销商之间的策略联盟日益普遍，从而能够提供捆绑式解决方案，以应对安全性和物流方面的复杂性。

采取实际措施加强可追溯性、实现采购多元化、使产品规格与最终用户需求保持一致，并加强与经销商的关係，以建立可持续的韧性。

产业领导者应优先采取一系列切实有效、影响深远的行动，以增强自身韧性、合规性和商业性地位。首先，应加强可追溯性和文件工作流程，以应对日益严格的监管询问并简化清关流程。实施标准化的分析证书、批次级追踪和第三方检验，将有助于减少贸易摩擦，并支援下游安全应用。

我们严谨的三角调查方法结合了初步访谈、监管分析和交叉检验的综合分析，以得出基于证据的、可操作的结论。

本调查方法融合了定性和定量方法，以确保对情况有全面、深入的理解。主要研究工作包括对采购主管、合规负责人、製造工程师、经销商和实验室经理进行结构化访谈，以收集有关供应链限制因素、品质要求和最终用户行为的第一手资讯。这些访谈旨在揭示营运实务和策略重点，而非收集财务敏感资讯。

对业务重点、监管要求和策略选择进行最终的综合分析，这些因素决定了竞争优势和供应链韧性。

这些结论提炼了对参与亚硝酸异丁酯生产、分销和最终用途的相关人员而言最重要的启示。在营运层面，更重视品质差异化、文件记录和合规分销将决定企业能否接触到关键客户群体以及能否跨多个司法管辖区企业发展。在策略层面，能够使产品规格与製药、实验室和工业买家的严格要求保持一致的企业，将减少摩擦并创造具有竞争力的价值提案。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章 美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 异丁基亚硝酸盐市场依产品类型划分

  • 工业级
  • 医药级
  • 试剂级

9. 异丁基亚硝酸盐市场按应用领域划分

  • 工业的
  • 实验室试剂
  • 医疗用途
  • 休閒用途

第十章 亚硝酸异丁酯市场（以最终用户划分）

  • 化学製造
  • 消费者市场
  • 医疗设施
  • 研究所

第十一章 异丁基亚硝酸盐市场按分销管道划分

  • 化学品经销商
    • 零售经销商
    • 经销商
  • 在线的
  • 药局
    • 医院药房
    • 零售药房

第十二章 异丁基亚硝酸盐市场区域划分

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 亚硝酸异丁酯市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 各国异丁基亚硝酸盐市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

15. 美国异丁基亚硝酸酯市场

第十六章：中国亚硝酸异丁酯市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Accela ChemBio Inc.
  • Avantor, Inc.
  • Brenntag SE
  • Cayman Chemical Company
  • Focus Chemicals Ltd
  • Merck KGaA
  • Otto Chemi Pvt. Ltd.
  • Spectrum Chemical Manufacturing Corp.
  • Thermo Fisher Scientific Inc.
  • Tokyo Chemical Industry Co., Ltd.
  • Univar Solutions Inc.
  • Vizag Chemi Pvt. Ltd.
Product Code: MRR-F847BD9C7158

The Isobutyl Nitrite Market was valued at USD 159.32 million in 2025 and is projected to grow to USD 172.94 million in 2026, with a CAGR of 7.89%, reaching USD 271.16 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 159.32 million
Estimated Year [2026] USD 172.94 million
Forecast Year [2032] USD 271.16 million
CAGR (%) 7.89%

A clear and authoritative framing of isobutyl nitrite's current role across industrial applications, regulatory pressures, and strategic supply chain considerations

The executive summary synthesizes the complex, cross-disciplinary considerations that define the current landscape for isobutyl nitrite. This introduction frames the compound's diverse industrial and laboratory roles, the nuanced regulatory context affecting its manufacture, distribution, and use, and the intersecting dynamics of supply chains and consumer behavior. It positions the ensuing analysis to inform procurement, compliance, and strategy teams seeking clarity in an evolving environment.

Contextualizing the substance across product quality distinctions, end-user needs, and distribution pathways helps to surface the levers that organizations must manage to maintain continuity and regulatory alignment. The introduction also clarifies the scope of the study: a structured review of product categories, application profiles, end-user segmentation, and distribution channels tied to regional regulatory and commercial realities. By establishing these parameters up front, the report guides readers toward the most consequential insights and strategic decisions, while highlighting the operational trade-offs that arise under shifting policy and market conditions.

How manufacturing innovations, tightening regulatory regimes, and digitalized supply chains are fundamentally reshaping production, distribution, and end-user dynamics

The landscape for isobutyl nitrite is undergoing several transformative shifts that are reshaping production, distribution, and end-user engagement. Advances in manufacturing process controls and purer synthesis routes are elevating product quality options and creating clearer differentiation between industrial grade, pharmaceutical grade, and reagent grade variants. At the same time, regulatory frameworks are tightening in multiple jurisdictions, prompting manufacturers and distributors to reinforce compliance protocols and traceability across the supply chain.

Concurrently, evolving consumption patterns are altering application mixes. Laboratory and medical demand is increasingly driven by precision and provenance, while other channels reflect a more fragmented set of drivers that include convenience, cost, and perceived safety. Digital channels are accelerating procurement workflows, integrating supplier verification and expedited logistics, and enabling new entrants to access specialized end users. These shifts are compelling legacy players to invest in quality assurance, supply-chain digitization, and targeted stakeholder engagement to preserve market access and reduce trade friction. As a result, competitive advantage is migrating toward organizations that can couple compliant production practices with nimble, data-driven distribution capabilities.

Navigating the operational and strategic repercussions of tariff changes across sourcing, compliance, and logistics for isobutyl nitrite stakeholders

Policy changes in the United States in 2025 have added a new layer of complexity for manufacturers, importers, and downstream users of isobutyl nitrite. Tariff adjustments and related trade measures have prompted reassessments of sourcing strategies and routing decisions, as stakeholders seek to preserve continuity while managing added administrative burdens. These developments have incentivized firms to explore alternative sourcing, nearshoring, and greater vertical integration to mitigate exposure to trade-policy volatility.

Operationally, affected organizations have had to enhance customs documentation, expand compliance teams, and recalibrate supplier contracts to reflect new cost structures and lead-time uncertainties. The cumulative impact also extends to logistics planning, where carriers and third-party providers are being evaluated for their ability to deliver predictable transit and customs clearance services. In response, some enterprises are deepening collaborations with trusted suppliers to secure preferential handling and certification pathways, and are investing in scenario planning to quantify potential supply interruptions. Importantly, organizational resilience now hinges on the ability to align procurement, legal, and commercial functions to navigate the evolving tariff landscape while preserving product integrity and regulatory compliance.

A layered segmentation framework linking product grades, application pathways, end-user profiles, and distribution channels to reveal where value and compliance risks concentrate

Detailed segmentation illuminates where value and risk concentrate across product formulations, usage profiles, end-user types, and distribution avenues. Based on Product Type, the analysis distinguishes Industrial Grade, Pharmaceutical Grade, and Reagent Grade, each carrying distinct quality specifications, certification requirements, and suitability for different downstream processes. Based on Application, demand is categorized into Industrial Use, Laboratory Reagent, Medical Use, and Recreational Use; the Recreational Use segment is further examined through Consumer Demographic cohorts segmented into 18-25, 26-35, and Above 35, which reveal divergent purchasing behaviors and risk perceptions.

Based on End User, the study covers Chemical Manufacturing, Consumer Market, Healthcare Facilities, and Research Laboratories, with Research Laboratories further broken down by Organization Type into Government Labs, Private Research Institutes, and Universities to show how procurement policies and funding cycles shape sourcing preferences. Based on Distribution Channel, the work analyzes Chemical Distributors, Online, and Pharmacies; Chemical Distributors are further parsed into Retail Distributors and Wholesale Distributors, while Online pathways are evaluated by Platform Type-E-Commerce Platforms, Manufacturer Websites, and Third-Party Marketplaces-and Pharmacies are delineated into Hospital Pharmacies and Retail Pharmacies. This layered segmentation facilitates targeted recommendations by connecting product grades to application suitability, end-user procurement behaviors, and channel economics, thereby enabling stakeholders to prioritize investments and compliance efforts according to the most relevant demand drivers.

How regional regulatory diversity, procurement practices, and industrial capacity across major global regions are shaping supplier strategies and distribution models

Regional dynamics exert a decisive influence on production choices, regulatory compliance, and channel strategies. In the Americas, regulatory enforcement and customs practices vary substantially across jurisdictions, requiring supply chain managers to maintain differentiated compliance playbooks and localized distribution strategies. Regulatory dialogue and enforcement trends in this region are shaping how companies document provenance, certify purity, and manage controlled distribution for sensitive applications.

Europe, Middle East & Africa present a heterogeneous regulatory tapestry in which harmonization efforts coexist with country-specific controls; as a result, companies operating across this region must balance centralized quality systems with localized registration and reporting obligations. Differences in healthcare procurement and laboratory funding models further affect demand characteristics across these markets. Asia-Pacific is characterized by rapid industrialization, a dense manufacturing base, and an expanding domestic research ecosystem, which together create both sourcing opportunities and jurisdictional compliance challenges. Across these regions, strategic actors are prioritizing localized regulatory expertise, supply-chain diversification, and adaptive distribution models to manage cross-border friction while capturing region-specific demand for different product grades and applications.

Competitive differentiation driven by quality assurance, compliance programs, digital distribution, and strategic manufacturer-distributor partnerships

Competitive dynamics in the isobutyl nitrite landscape reflect a mix of legacy chemical producers, specialty suppliers, and agile digital-first distributors. Leading organizations are differentiating through investments in quality assurance, regulatory compliance programs, and traceability platforms that demonstrate chain-of-custody and analytical provenance. Strategic partnerships between manufacturers and certified distributors are becoming more common, enabling bundled offerings that address both safety and logistical complexity.

Innovative entrants are leveraging digital channels to provide transparent product information, expedited fulfillment, and targeted marketing to niche end users such as research institutes and specific healthcare facilities. At the same time, incumbent players are responding with upgraded capabilities in process control, third-party certification, and contractual frameworks that lock in long-term supply relationships. Across the competitive set, intellectual property around purification methods, documentation workflows, and compliance processes represents a growing source of differentiation. In sum, success now depends on blending operational excellence with regulatory foresight and channel-focused go-to-market strategies that align with customer procurement processes.

Actionable steps to strengthen traceability, diversify sourcing, align product specifications with end-user needs, and fortify distributor relationships for sustained resilience

Industry leaders should prioritize a set of pragmatic, high-impact actions to strengthen resilience, compliance, and commercial positioning. First, enhance traceability and documentation workflows to satisfy increasingly stringent regulatory inquiries and to facilitate smoother customs clearance. Implementing standardized certificates of analysis, batch-level tracking, and third-party verification will reduce transaction friction and support safe downstream use.

Second, diversify sourcing and logistics pathways to mitigate concentrated risk arising from policy shifts and supplier disruptions. Nearshoring, multi-sourcing, and contractual flexibility can provide critical breathing room during periods of tariff or regulatory uncertainty. Third, invest in targeted product differentiation: aligning product specifications with the needs of pharmaceutical, laboratory, and industrial end users improves fit and reduces the risk of misapplication. Fourth, strengthen distributor relationships and segment-specific go-to-market motions to ensure reliable channel performance, particularly where pharmacies and online platforms serve as important access points. Finally, proactively engage with regulators and standards bodies to shape pragmatic compliance regimes and to anticipate reporting expectations. Taken together, these steps create a more defensible position against regulatory volatility while opening incremental commercial opportunities.

A rigorous, triangulated methodology combining primary interviews, regulatory analysis, and cross-validated synthesis to ensure evidence-based, actionable conclusions

The research methodology integrates qualitative and quantitative approaches to ensure a robust, triangulated understanding of the landscape. Primary research included structured interviews with procurement leads, compliance officers, manufacturing technologists, distributors, and laboratory managers to capture firsthand perspectives on supply-chain constraints, quality requirements, and end-use behaviors. These interviews were designed to surface operational practices and strategic priorities rather than to collect proprietary financial disclosures.

Secondary research encompassed a systematic review of regulatory statutes, customs guidance, technical monographs, and publicly available industry literature to map the normative requirements and technical attributes that define product grades. Data synthesis applied a triangulation approach: cross-referencing interview insights with publicly available regulatory documents and supplier literature to validate themes and identify divergences. Throughout, methodological rigor emphasized transparency in source provenance, careful treatment of confidential interview material, and sensitivity to jurisdictional variation. The result is an evidence-based narrative that links operational realities to regulatory obligations and commercial strategy without relying on single-source conclusions.

Concluding synthesis of operational priorities, regulatory imperatives, and strategic choices that will define competitive advantage and supply-chain resilience

The conclusion distills the most consequential implications for stakeholders engaged with isobutyl nitrite across production, distribution, and end use. Operationally, a heightened focus on quality differentiation, documentation, and compliant distribution will determine access to critical customer segments and the ability to operate across jurisdictions. Strategically, firms that align product specifications with the precise requirements of pharmaceutical, laboratory, and industrial buyers will reduce friction and create defensible value propositions.

Moreover, resilience in the face of trade-policy shifts and regulatory tightening depends on integrated planning across procurement, legal, and commercial functions, paired with investments in traceability and supplier diversification. Finally, the competitive environment rewards organizations that combine manufacturing discipline with go-to-market sophistication-those that can demonstrate provenance, certify quality, and deliver reliably through the right channels will secure advantaged positions as regulatory scrutiny and buyer expectations continue to evolve.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Isobutyl Nitrite Market, by Product Type

  • 8.1. Industrial Grade
  • 8.2. Pharmaceutical Grade
  • 8.3. Reagent Grade

9. Isobutyl Nitrite Market, by Application

  • 9.1. Industrial Use
  • 9.2. Laboratory Reagent
  • 9.3. Medical Use
  • 9.4. Recreational Use

10. Isobutyl Nitrite Market, by End User

  • 10.1. Chemical Manufacturing
  • 10.2. Consumer Market
  • 10.3. Healthcare Facilities
  • 10.4. Research Laboratories

11. Isobutyl Nitrite Market, by Distribution Channel

  • 11.1. Chemical Distributors
    • 11.1.1. Retail Distributors
    • 11.1.2. Wholesale Distributors
  • 11.2. Online
  • 11.3. Pharmacies
    • 11.3.1. Hospital Pharmacies
    • 11.3.2. Retail Pharmacies

12. Isobutyl Nitrite Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Isobutyl Nitrite Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Isobutyl Nitrite Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Isobutyl Nitrite Market

16. China Isobutyl Nitrite Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Accela ChemBio Inc.
  • 17.6. Avantor, Inc.
  • 17.7. Brenntag SE
  • 17.8. Cayman Chemical Company
  • 17.9. Focus Chemicals Ltd
  • 17.10. Merck KGaA
  • 17.11. Otto Chemi Pvt. Ltd.
  • 17.12. Spectrum Chemical Manufacturing Corp.
  • 17.13. Thermo Fisher Scientific Inc.
  • 17.14. Tokyo Chemical Industry Co., Ltd.
  • 17.15. Univar Solutions Inc.
  • 17.16. Vizag Chemi Pvt. Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ISOBUTYL NITRITE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ISOBUTYL NITRITE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ISOBUTYL NITRITE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES ISOBUTYL NITRITE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA ISOBUTYL NITRITE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ISOBUTYL NITRITE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY INDUSTRIAL GRADE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY INDUSTRIAL GRADE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY INDUSTRIAL GRADE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY PHARMACEUTICAL GRADE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY PHARMACEUTICAL GRADE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY PHARMACEUTICAL GRADE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY REAGENT GRADE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY REAGENT GRADE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY REAGENT GRADE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY INDUSTRIAL USE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY INDUSTRIAL USE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY INDUSTRIAL USE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY LABORATORY REAGENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY LABORATORY REAGENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY LABORATORY REAGENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY MEDICAL USE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY MEDICAL USE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY MEDICAL USE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY RECREATIONAL USE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY RECREATIONAL USE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY RECREATIONAL USE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY CHEMICAL MANUFACTURING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY CHEMICAL MANUFACTURING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY CHEMICAL MANUFACTURING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY CONSUMER MARKET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY CONSUMER MARKET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY CONSUMER MARKET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY HEALTHCARE FACILITIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY HEALTHCARE FACILITIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY HEALTHCARE FACILITIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY RESEARCH LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY RESEARCH LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY CHEMICAL DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY CHEMICAL DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY CHEMICAL DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY CHEMICAL DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY RETAIL DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY RETAIL DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY RETAIL DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY WHOLESALE DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY WHOLESALE DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY WHOLESALE DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. AMERICAS ISOBUTYL NITRITE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS ISOBUTYL NITRITE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS ISOBUTYL NITRITE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS ISOBUTYL NITRITE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS ISOBUTYL NITRITE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS ISOBUTYL NITRITE MARKET SIZE, BY CHEMICAL DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS ISOBUTYL NITRITE MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA ISOBUTYL NITRITE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. NORTH AMERICA ISOBUTYL NITRITE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA ISOBUTYL NITRITE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA ISOBUTYL NITRITE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA ISOBUTYL NITRITE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA ISOBUTYL NITRITE MARKET SIZE, BY CHEMICAL DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA ISOBUTYL NITRITE MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 77. LATIN AMERICA ISOBUTYL NITRITE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. LATIN AMERICA ISOBUTYL NITRITE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. LATIN AMERICA ISOBUTYL NITRITE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA ISOBUTYL NITRITE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA ISOBUTYL NITRITE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 82. LATIN AMERICA ISOBUTYL NITRITE MARKET SIZE, BY CHEMICAL DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA ISOBUTYL NITRITE MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA ISOBUTYL NITRITE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA ISOBUTYL NITRITE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA ISOBUTYL NITRITE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA ISOBUTYL NITRITE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA ISOBUTYL NITRITE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA ISOBUTYL NITRITE MARKET SIZE, BY CHEMICAL DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA ISOBUTYL NITRITE MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE ISOBUTYL NITRITE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE ISOBUTYL NITRITE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE ISOBUTYL NITRITE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE ISOBUTYL NITRITE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE ISOBUTYL NITRITE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE ISOBUTYL NITRITE MARKET SIZE, BY CHEMICAL DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE ISOBUTYL NITRITE MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 98. MIDDLE EAST ISOBUTYL NITRITE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. MIDDLE EAST ISOBUTYL NITRITE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. MIDDLE EAST ISOBUTYL NITRITE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST ISOBUTYL NITRITE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 102. MIDDLE EAST ISOBUTYL NITRITE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 103. MIDDLE EAST ISOBUTYL NITRITE MARKET SIZE, BY CHEMICAL DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST ISOBUTYL NITRITE MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 105. AFRICA ISOBUTYL NITRITE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. AFRICA ISOBUTYL NITRITE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. AFRICA ISOBUTYL NITRITE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 108. AFRICA ISOBUTYL NITRITE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 109. AFRICA ISOBUTYL NITRITE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 110. AFRICA ISOBUTYL NITRITE MARKET SIZE, BY CHEMICAL DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 111. AFRICA ISOBUTYL NITRITE MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC ISOBUTYL NITRITE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC ISOBUTYL NITRITE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC ISOBUTYL NITRITE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC ISOBUTYL NITRITE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC ISOBUTYL NITRITE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC ISOBUTYL NITRITE MARKET SIZE, BY CHEMICAL DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC ISOBUTYL NITRITE MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. ASEAN ISOBUTYL NITRITE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. ASEAN ISOBUTYL NITRITE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. ASEAN ISOBUTYL NITRITE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 123. ASEAN ISOBUTYL NITRITE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 124. ASEAN ISOBUTYL NITRITE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 125. ASEAN ISOBUTYL NITRITE MARKET SIZE, BY CHEMICAL DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 126. ASEAN ISOBUTYL NITRITE MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 127. GCC ISOBUTYL NITRITE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GCC ISOBUTYL NITRITE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. GCC ISOBUTYL NITRITE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 130. GCC ISOBUTYL NITRITE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. GCC ISOBUTYL NITRITE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 132. GCC ISOBUTYL NITRITE MARKET SIZE, BY CHEMICAL DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 133. GCC ISOBUTYL NITRITE MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPEAN UNION ISOBUTYL NITRITE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPEAN UNION ISOBUTYL NITRITE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPEAN UNION ISOBUTYL NITRITE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPEAN UNION ISOBUTYL NITRITE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPEAN UNION ISOBUTYL NITRITE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPEAN UNION ISOBUTYL NITRITE MARKET SIZE, BY CHEMICAL DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPEAN UNION ISOBUTYL NITRITE MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 141. BRICS ISOBUTYL NITRITE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. BRICS ISOBUTYL NITRITE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. BRICS ISOBUTYL NITRITE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. BRICS ISOBUTYL NITRITE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. BRICS ISOBUTYL NITRITE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 146. BRICS ISOBUTYL NITRITE MARKET SIZE, BY CHEMICAL DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 147. BRICS ISOBUTYL NITRITE MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 148. G7 ISOBUTYL NITRITE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 149. G7 ISOBUTYL NITRITE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. G7 ISOBUTYL NITRITE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 151. G7 ISOBUTYL NITRITE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. G7 ISOBUTYL NITRITE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 153. G7 ISOBUTYL NITRITE MARKET SIZE, BY CHEMICAL DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 154. G7 ISOBUTYL NITRITE MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 155. NATO ISOBUTYL NITRITE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. NATO ISOBUTYL NITRITE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. NATO ISOBUTYL NITRITE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 158. NATO ISOBUTYL NITRITE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 159. NATO ISOBUTYL NITRITE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 160. NATO ISOBUTYL NITRITE MARKET SIZE, BY CHEMICAL DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 161. NATO ISOBUTYL NITRITE MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. UNITED STATES ISOBUTYL NITRITE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 164. UNITED STATES ISOBUTYL NITRITE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. UNITED STATES ISOBUTYL NITRITE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 166. UNITED STATES ISOBUTYL NITRITE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. UNITED STATES ISOBUTYL NITRITE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 168. UNITED STATES ISOBUTYL NITRITE MARKET SIZE, BY CHEMICAL DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 169. UNITED STATES ISOBUTYL NITRITE MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 170. CHINA ISOBUTYL NITRITE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 171. CHINA ISOBUTYL NITRITE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. CHINA ISOBUTYL NITRITE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 173. CHINA ISOBUTYL NITRITE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 174. CHINA ISOBUTYL NITRITE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 175. CHINA ISOBUTYL NITRITE MARKET SIZE, BY CHEMICAL DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 176. CHINA ISOBUTYL NITRITE MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)